InventisBio (Shanghai) Co.
Latest round
- Series D
Last raised
- Sep 2020
Total raised
- $247M
Investors
- 13
About InventisBio (Shanghai) Co.
, Ltd. is a biopharmaceutical company that focuses on the development of drugs for tumors and metabolic diseases. In 2022, the company was listed on the Shanghai Stock Exchange. Its stock code is 688382. Yaolin Wang is the co-founder, chairman and general manager of the company. The company's main products include oncology drug D-0502, D-1553 and metabolic disease drug D-0120, etc. D-1553 is used in non-small cell lung cancer and colorectal cancer.
Who invested in InventisBio (Shanghai) Co.
13 investors across 4 rounds
See all investors in InventisBio (Shanghai) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InventisBio (Shanghai) Co.
Who invested in InventisBio (Shanghai) Co.?
InventisBio (Shanghai) Co. has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InventisBio (Shanghai) Co. raised?
InventisBio (Shanghai) Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did InventisBio (Shanghai) Co. last raise money?
InventisBio (Shanghai) Co.'s most recent round on record is a Series D, in Sep 2020.
What does InventisBio (Shanghai) Co. do?
InventisBio (Shanghai) Co. is a pharmaceuticals company.
Where is InventisBio (Shanghai) Co. headquartered?
InventisBio (Shanghai) Co. is headquartered in Shanghai, China.
Which VCs invest in companies like InventisBio (Shanghai) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at InventisBio (Shanghai) Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like InventisBio (Shanghai) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.